12:00 PM EST - Intellipharmaceutics International Inc. : Announced that its United States marketing partner, Par Pharmaceutical, has launched the 25 and 35 mg strengths of its generic Focalin XR® (dexmethylphenidate hydrochloride extended-release) capsules in the U.S. Intellipharmaceutics International Inc.
shares T.I are trading up $0.04 at $3.79.
